PROVIDENCE – ProThera Biologics has appointed Denice M. Spero as president and chief business officer. ProThera Biologics is a biomedical company developing therapies to treat life-threatening diseases. Spero, according to the company, will strengthen its efforts to advance its inter-alpha inhibitor proteins into clinical development. She also will assume a leadership role in business development…
Want More Free?
To access 2 more articles, please log in or register for free.
Registered users get access to a limited number of free articles every month.